OSCR

TCF1+CD4+ T cells and microglia co-orchestrate tertiary lymphoid structures to enhance prognosis and immunotherapy in non-small cell lung cancer with brain metastases.

Overview

Authors: Qian Yu1,2, Rongxin Liao1,2, Haoyu Zheng3,4, Lin Li5, Yusheng Huang1, Yihao Tao6, Rui Deng1,2, Hengqiu He1,2, Li Yu7, Jingyao Lin1,2, Shunping Huang1,2, Xiaoyue Zhang1,2, Zaicheng Xu1,2, Zhenzhou Yang1,2, Yuan Peng1,2
  1. Department of Cancer Center, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, 400010, China
  2. Chongqing Key Laboratory of Immunotherapy, Chongqing, 400010, China
  3. Department of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China
  4. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China
  5. Department of Neurosurgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400000, China
  6. Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, 400010, China
  7. Department of Endocrinology, Armed Police Hospital of Chongqing, Chongqing, 400061, China
Journal: EBioMedicine, volume 127, article 106280
Dates: received 7 November 2025; accepted 17 April 2026; published online 4 May 2026; in print May 2026
Type: Research article · Language: English
License: CC BY-NC-ND
Identifiers: DOI 10.1016/j.ebiom.2026.106280 · PMID 42085932 · PMCID PMC13157008 · OpenAlex W7160210087
Open access: gold, a free copy (OpenAlex)
Categories: human (organism), mouse (organism), other condition (population), cellular / molecular (subfield)
Methods: Statistics, Smoothing, state filtering, decompositions, Connectivity, Machine learning
Keywords: Tertiary lymphoid structures, Brain metastases, Non-small cell lung cancer, TCF1+CD4 T cells, Microglia, CXCL12
MeSH: Brain Neoplasms*, Carcinoma, Non-Small-Cell Lung*, CD4-Positive T-Lymphocytes*, Lung Neoplasms*, Microglia*, Tertiary Lymphoid Structures*, Animals, Disease Models, Animal, Female, Humans, Immunotherapy, Lymphocytes, Tumor-Infiltrating, Male, Mice, Middle Aged, Prognosis, Tumor Microenvironment (* major topic)
Topic: Neuroinflammation and Neurodegeneration Mechanisms (Neurology, Neuroscience), according to OpenAlex
Citations: not cited yet (Europe PMC); 61 references in the paper
Research resources: RRID:AB_10949053, with a rat IgG antibody RRID:AB_1107769, RRID:AB_1107771, hereafter referred to as LLC RRID:CVCL_4358

Abstract

The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Data links

Data availability statement

The paper has a data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:

  • it says that the data are available on request

Read it in the paper: doi.org/10.1016/j.ebiom.2026.106280.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 15 authors, 6 keywords, 17 MeSH terms, 2 funders, 60 references, 4 RRIDs.

Cite

This paper

Yu, Q., Liao, R., Zheng, H., Li, L., Huang, Y., Tao, Y., Deng, R., He, H., Yu, L., Lin, J., Huang, S., Zhang, X., Xu, Z., Yang, Z., & Peng, Y. (2026). TCF1+CD4+ T cells and microglia co-orchestrate tertiary lymphoid structures to enhance prognosis and immunotherapy in non-small cell lung cancer with brain metastases. EBioMedicine, 127, 106280. https://doi.org/10.1016/j.ebiom.2026.106280

BibTeX

@article{yu2026tcf1,
author = {Yu, Qian and Liao, Rongxin and Zheng, Haoyu and Li, Lin and Huang, Yusheng and Tao, Yihao and Deng, Rui and He, Hengqiu and Yu, Li and Lin, Jingyao and Huang, Shunping and Zhang, Xiaoyue and Xu, Zaicheng and Yang, Zhenzhou and Peng, Yuan},
title = {{TCF1+CD4+ T cells and microglia co-orchestrate tertiary lymphoid structures to enhance prognosis and immunotherapy in non-small cell lung cancer with brain metastases}},
journal = {EBioMedicine},
year = {2026},
month = may,
volume = {127},
pages = {106280},
publisher = {Elsevier},
issn = {2352-3964},
doi = {10.1016/j.ebiom.2026.106280},
url = {https://doi.org/10.1016/j.ebiom.2026.106280},
pmid = {42085932},
pmcid = {PMC13157008}
}

RIS

TY - JOUR
AU - Yu, Qian
AU - Liao, Rongxin
AU - Zheng, Haoyu
AU - Li, Lin
AU - Huang, Yusheng
AU - Tao, Yihao
AU - Deng, Rui
AU - He, Hengqiu
AU - Yu, Li
AU - Lin, Jingyao
AU - Huang, Shunping
AU - Zhang, Xiaoyue
AU - Xu, Zaicheng
AU - Yang, Zhenzhou
AU - Peng, Yuan
TI - TCF1+CD4+ T cells and microglia co-orchestrate tertiary lymphoid structures to enhance prognosis and immunotherapy in non-small cell lung cancer with brain metastases
T2 - EBioMedicine
J2 - EBioMedicine
PY - 2026
DA - 2026/05/04
VL - 127
SP - 106280
SN - 2352-3964
PB - Elsevier
DO - 10.1016/j.ebiom.2026.106280
UR - https://doi.org/10.1016/j.ebiom.2026.106280
LA - en
ER -

CSL-JSON

{
"id": "10.1016/j.ebiom.2026.106280",
"type": "article-journal",
"title": "TCF1+CD4+ T cells and microglia co-orchestrate tertiary lymphoid structures to enhance prognosis and immunotherapy in non-small cell lung cancer with brain metastases",
"container-title": "EBioMedicine",
"author": [
{
"family": "Yu",
"given": "Qian"
},
{
"family": "Liao",
"given": "Rongxin"
},
{
"family": "Zheng",
"given": "Haoyu"
},
{
"family": "Li",
"given": "Lin"
},
{
"family": "Huang",
"given": "Yusheng"
},
{
"family": "Tao",
"given": "Yihao"
},
{
"family": "Deng",
"given": "Rui"
},
{
"family": "He",
"given": "Hengqiu"
},
{
"family": "Yu",
"given": "Li"
},
{
"family": "Lin",
"given": "Jingyao"
},
{
"family": "Huang",
"given": "Shunping"
},
{
"family": "Zhang",
"given": "Xiaoyue"
},
{
"family": "Xu",
"given": "Zaicheng"
},
{
"family": "Yang",
"given": "Zhenzhou"
},
{
"family": "Peng",
"given": "Yuan"
}
],
"container-title-short": "EBioMedicine",
"volume": "127",
"page": "106280",
"DOI": "10.1016/j.ebiom.2026.106280",
"PMID": "42085932",
"PMCID": "PMC13157008",
"ISSN": "2352-3964",
"publisher": "Elsevier",
"URL": "https://doi.org/10.1016/j.ebiom.2026.106280",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
4
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s12967-026-07852-5
Clinical and immunological significance of tertiary lymphoid structure maturation heterogeneity in brain metastases of lung adenocarcinoma.
Journal: Journal of translational medicine
In common: other condition, 7 references
[2] doi:10.1186/s40478-025-02007-x
Identification and characterization of tertiary lymphoid structures in brain metastases.
Journal: Acta neuropathologica communications
In common: other condition, cellular / molecular, 6 references
[3] doi:10.1073/pnas.2425081122 [code]
Dural ectopic lymphatic structures accumulate during aging and exhibit dysregulation in neurodegenerative diseases.
Journal: Proceedings of the National Academy of Sciences of the United States of America
In common: other condition, mouse, cellular / molecular, 5 references
[4] doi:10.1038/s43018-023-00547-6
CD103<sup>+</sup> regulatory T cells underlie resistance to radio-immunotherapy and impair CD8<sup>+</sup> T cell activation in glioblastoma.
Journal: Nature cancer
In common: other condition, mouse, 4 references
[5] doi:10.3390/cancers17081303
Tertiary Lymphoid Structures Are Associated with Progression-Free Survival of Peripheral Neuroblastic Tumor Patients.
Journal: Cancers
In common: other condition, 4 references
[6] doi:10.1038/s41467-026-68748-y
A proteogenomic atlas of 1032 brain metastases identifies molecular subtypes, immune landscapes, and therapeutic vulnerabilities.
Journal: Nature communications
In common: other condition, cellular / molecular, 4 references
[7] doi:10.1186/s40164-023-00412-3
Outcome differences between PD-1/PD-L1 inhibitors-based monotherapy and combination treatments in NSCLC with brain metastases.
Journal: Experimental hematology & oncology
In common: other condition, 4 references
[8] doi:10.1093/bib/bbaf365 [code]
Path-MGCN: a pathway activity-based multi-view graph convolutional network for determining spatial domains.
Journal: Briefings in bioinformatics
In common: other condition, mouse, 3 references
[9] doi:10.1038/s41467-026-74782-7
Anti-PD-1 plus anti-CTLA-4 blockade overcomes immune exclusion in NSCLC brain metastases by enhancing CD8&lt;sup&gt;+&lt;/sup&gt; T cell responses and promoting tertiary lymphoid structure formation.
Journal: Nature communications
In common: other condition, mouse, cellular / molecular, 2 references
[10] doi:10.1038/s41467-026-71759-4 [code]
CellNiche represents cellular microenvironments in atlas-scale spatial omics data with contrastive learning.
Journal: Nature communications
In common: other condition, mouse, cellular / molecular, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.